In the BioHarmony Drug Report Database
Pegcetacoplan
Empaveli (pegcetacoplan) is a protein pharmaceutical. Pegcetacoplan was first approved as Empaveli on 2021-05-14. Empaveli’s patents are valid until 2038-04-09 (FDA).
Trade Name
|
Empaveli |
|---|---|
Common Name
|
pegcetacoplan |
ChEMBL ID
|
CHEMBL4298211 |
Indication
|
|
Drug Class
|
Pegylated compounds |
Image (chem structure or protein)
